Author: Jimmy He PharmD, DSc

State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention

State of the Science: What We Know about Long-Acting Injectable Agents for HIV PreventionPresenter: Colleen Kelley, MP, MPH Click to Download Slides On-Demand Webcast Podcast iasusa · State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention Text on the button
DETAIL

Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles Heel

Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles HeelPresenter: Joseph J. Eron, Jr, MD Click to Download Slides On-Demand Webcast Podcast iasusa · Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles Heel Text on the button
DETAIL

Annoying But Necessary: Navigating the Operational Challenges of Long-Acting Treatment and Prevention Strategies

Annoying But Necessary: Navigating the Operational Challenges of Long-Acting Treatment and Prevention StrategiesPresenter: Joshua P. Havens, PharmD Click to Download Slides On-Demand Webcast Podcast iasusa · Annoying But Necessary: Navigating the Challenges of LA Treatment & Prevention Strategies Text on the button
DETAIL

Challenging Cases in Long-Acting Treatment and Prevention: What Would You Do?

Challenging Cases in Long-Acting Treatment and Prevention: What Would You Do?Presenter: Raphael J. Landovitz, MD, MSc Click to Download Slides On-Demand Webcast Podcast iasusa · Challenging Cases in LA Treatment and Prevention: What Would You Do? Text on the button
DETAIL

Phage Therapy From Bench to Bedside, and Back Again

Phage Therapy From Bench to Bedside, and Back AgainDaria Van Tyne On-Demand Webcast
DETAIL

Integrating Phage Biology and Therapeutic Potential

Integrating Phage Biology and Therapeutic PotentialMartha Clokie On-Demand Webcast
DETAIL

Phage Evolution in Vitro and In Vivo

Phage Evolution in Vitro and In VivoPaul E. Turner On-Demand Webcast
DETAIL

Phages vs. Biofilms: Advancing Phage Therapy for Complex Prosthetic Joint Infections due to Staphylococci

Phages vs. Biofilms: Advancing Phage Therapy for Complex Prosthetic Joint Infections due to StaphylococciTristan Ferry On-Demand Webcast
DETAIL

Diversity of Microviruses: What We Know and What We Don’t Know

Diversity of Microviruses: What We Know and What We Don’t KnowPaul Kirchberger On-Demand Webcast
DETAIL

Synthetic Phage Genomes: Assembly and Rebooting

Synthetic Phage Genomes: Assembly and RebootingErica Hartmann On-Demand Webcast
DETAIL